Multiscale simulation demonstrates two- and three-photon absorption in ChR2, revealing insights for optogenetics.
Channelrhodopsin-2 (ChR2) is a light-gated ion channel widely used in optogenetics, a technique that enables precise control of neuronal activity by genetically engineering light-sensitive proteins into cell membranes. This protein exists in dimeric form, with each monomer containing a retinal Schiff base (RSB) moiety covalently bonded that undergoes trans-cis isomerization upon light absorption. However, the limited penetration depth of visible light in biological tissues motivates the use of multiphoton-absorption techniques, which enhance tissue penetration, improve focality, and reduce phototoxicity, thereby offering a promising alternative for optogenetic applications. In this paper, we present a fully atomistic multiscale methodology for computing the one-, two-, and three-photon absorption spectra of ChR2, where the protein, lipid bilayer, and solvent are explicitly considered throughout the workflow. This methodology integrates classical MD, QM/MM MD, and fragment-based polarizable embedding (PE) to derive environment-specific PE potentials from the explicit protein–lipid–solvent environment. The final step in the methodology is to use these potentials to compute accurate spectra via PE-TD-DFT. Validation against experimental one-photon absorption spectra demonstrates excellent agreement. For the first time, we report the theoretical two- and three-photon absorption in ChR2, albeit without direct experimental comparison. We compare the MPA spectra where the two RSB moieties are sampled using classical MD and QM/MM MD, respectively. The resulting spectral differences are attributed to variations in key structural parameters that we analyze and document.
No takes yet. Share an insight, caveat, or question.
Carrasco‐Busturia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: